G1 Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of G1 Therapeutics (GTHX) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in G1 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including G1 Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in G1 Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $55k | 18k | 3.10 |
| 2023-09-30 | $26k | 18k | 1.46 |
| 2023-06-30 | $45k | 18k | 2.53 |
| 2023-03-31 | $48k | 18k | 2.70 |
| 2022-12-31 | $257k | 47k | 5.43 |
| 2022-03-31 | $1.3M | 175k | 7.60 |
| 2021-12-31 | $8.5M | 834k | 10.21 |
| 2021-09-30 | $11M | 824k | 13.42 |
| 2021-06-30 | $18M | 828k | 21.94 |
| 2021-03-31 | $39M | 1.6M | 24.06 |
| 2020-12-31 | $28M | 1.6M | 17.99 |
| 2020-09-30 | $17M | 1.5M | 11.55 |
| 2020-06-30 | $38M | 1.6M | 24.26 |
| 2020-03-31 | $16M | 1.5M | 11.02 |
| 2019-12-31 | $48M | 1.8M | 26.43 |
| 2019-09-30 | $42M | 1.8M | 22.78 |
| 2019-06-30 | $44M | 1.4M | 30.66 |
| 2019-03-31 | $25M | 1.5M | 16.60 |
| 2018-12-31 | $33M | 1.7M | 19.15 |
| 2018-09-30 | $102M | 1.9M | 52.29 |
| 2018-06-30 | $61M | 1.4M | 43.46 |
| 2018-03-31 | $41M | 1.1M | 37.05 |